TXG — 10X Genomics Inc · rev $642.8M

10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.

Latest reported TXG revenue for 2025-12-31 was $642.8M. Net income was -$43.5M. TXG currently screens at market cap $4.08B.

Use this TXG page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TXG quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TXG SEC filings page. Lician reads the product cache first so this HTML stays unique to 10X Genomics Inc even when a live quote feed is slow.

10X Genomics Inc latest statements (FY2025)

Latest cached year on this hub. Full TXG income, balance, and cash tables.

  • Revenue$642.8M
  • Net Income-$43.5M
  • Total Assets$1.04B
  • Total Debt$0
  • Free Cash Flow$130.1M

TXG recent filings